Cargando…

Cocaine Use Disorder (CUD): Current Clinical Perspectives

Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and society. Individuals with CUD face many barriers in accessing treatment for CUD, and most individuals with CUD never receive treatment. In this review, we provide an overview of CUD, including risk factors for CUD,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Elizabeth K C, Wolkowicz, Noah R, De Aquino, Joao P, MacLean, R Ross, Sofuoglu, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451050/
https://www.ncbi.nlm.nih.gov/pubmed/36093428
http://dx.doi.org/10.2147/SAR.S337338
_version_ 1784784653418233856
author Schwartz, Elizabeth K C
Wolkowicz, Noah R
De Aquino, Joao P
MacLean, R Ross
Sofuoglu, Mehmet
author_facet Schwartz, Elizabeth K C
Wolkowicz, Noah R
De Aquino, Joao P
MacLean, R Ross
Sofuoglu, Mehmet
author_sort Schwartz, Elizabeth K C
collection PubMed
description Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and society. Individuals with CUD face many barriers in accessing treatment for CUD, and most individuals with CUD never receive treatment. In this review, we provide an overview of CUD, including risk factors for CUD, common co-occurring disorders, acute and chronic effects of cocaine use, and currently available pharmacological and behavioral treatments. There are no FDA-approved pharmacological treatments for CUD. Future studies with larger sample sizes and testing treatment combinations are warranted. However, individuals with CUD and co-occurring disorders (eg, a mood or anxiety disorder) may benefit from medication treatments. There are behavioral interventions that have demonstrated efficacy in treating CUD – contingency management (CM) and cognitive-behavioral therapy for substance use disorders (CBT-SUD) in particular – however many barriers remain in delivering these treatments to patients. Following the discussion of current treatments, we highlight some promising emerging treatments, as well as offer a framework that can be used in building a treatment plan for individuals with CUD.
format Online
Article
Text
id pubmed-9451050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94510502022-09-08 Cocaine Use Disorder (CUD): Current Clinical Perspectives Schwartz, Elizabeth K C Wolkowicz, Noah R De Aquino, Joao P MacLean, R Ross Sofuoglu, Mehmet Subst Abuse Rehabil Review Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and society. Individuals with CUD face many barriers in accessing treatment for CUD, and most individuals with CUD never receive treatment. In this review, we provide an overview of CUD, including risk factors for CUD, common co-occurring disorders, acute and chronic effects of cocaine use, and currently available pharmacological and behavioral treatments. There are no FDA-approved pharmacological treatments for CUD. Future studies with larger sample sizes and testing treatment combinations are warranted. However, individuals with CUD and co-occurring disorders (eg, a mood or anxiety disorder) may benefit from medication treatments. There are behavioral interventions that have demonstrated efficacy in treating CUD – contingency management (CM) and cognitive-behavioral therapy for substance use disorders (CBT-SUD) in particular – however many barriers remain in delivering these treatments to patients. Following the discussion of current treatments, we highlight some promising emerging treatments, as well as offer a framework that can be used in building a treatment plan for individuals with CUD. Dove 2022-09-03 /pmc/articles/PMC9451050/ /pubmed/36093428 http://dx.doi.org/10.2147/SAR.S337338 Text en © 2022 Schwartz et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Schwartz, Elizabeth K C
Wolkowicz, Noah R
De Aquino, Joao P
MacLean, R Ross
Sofuoglu, Mehmet
Cocaine Use Disorder (CUD): Current Clinical Perspectives
title Cocaine Use Disorder (CUD): Current Clinical Perspectives
title_full Cocaine Use Disorder (CUD): Current Clinical Perspectives
title_fullStr Cocaine Use Disorder (CUD): Current Clinical Perspectives
title_full_unstemmed Cocaine Use Disorder (CUD): Current Clinical Perspectives
title_short Cocaine Use Disorder (CUD): Current Clinical Perspectives
title_sort cocaine use disorder (cud): current clinical perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451050/
https://www.ncbi.nlm.nih.gov/pubmed/36093428
http://dx.doi.org/10.2147/SAR.S337338
work_keys_str_mv AT schwartzelizabethkc cocaineusedisordercudcurrentclinicalperspectives
AT wolkowicznoahr cocaineusedisordercudcurrentclinicalperspectives
AT deaquinojoaop cocaineusedisordercudcurrentclinicalperspectives
AT macleanrross cocaineusedisordercudcurrentclinicalperspectives
AT sofuoglumehmet cocaineusedisordercudcurrentclinicalperspectives